Active Implantable Medical Devices Market By Product Segment Analysis (Implantable Cardioverter Defibrillators, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, Implantable Hearing Devices) and By Regional Analysis – Global Forecast by 2023 - 2028
The Active Implantable Medical Devices Market is expected to be around US$ 40.85 Billion by 2028 at a CAGR of 7.5% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
7
REPORT DESCRIPTION
Research and development need much time in every field and some are very near to the goal and some will achieve their goal at a later stage. These are all the products which are highly useful to human beings and which can be implanted into the human body by a medical practitioner. Active implantable medical device (AIMD) helps to protect the life of many people globally. Active implantable medical device refers to any dynamic therapeutic gadget which is proposed to be absolutely or halfway presented, surgically or therapeutically, into the human body or by restorative mediation into a characteristic opening, and which is expected to stay after the procedure. AIMD is gaining scope worldwide due to its
How Big is the Global Active Implantable Medical Devices Market?
The Active Implantable Medical Devices Market is expected to be around US$ 40.85 Billion by 2028 at a CAGR of 7.5% in the given forecast period.
The major driving factors of Active Implantable Medical Devices Market are as follows:
The restraining factors of Active Implantable Medical Devices Market are as follows:
The Active Implantable Medical Devices Market is segmented on the lines of its product and regional. Based on product segmentation it covers Implantable Cardioverter Defibrillators, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, Implantable Hearing Devices.The Active Implantable Medical Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Active Implantable Medical Devices Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Active Implantable Medical Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Active Implantable Medical Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and LivaNova PLC (U.K.). Whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), William Demant Holding A/S (Denmark), and Nurotron Biotechnology Co., Ltd. (China). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Active Implantable Medical Devices Market has been segmented as below:
By Product Segment Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Active Implantable Medical Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Active Implantable Medical Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Hearing Screening Equipment market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Active Implantable Medical Devices: Market Snapshot
4.2 Europe: Active Implantable Medical Devices Market, By Product
4.3 Active Implantable Medical Devices Market: Geographic Growth Opportunities
4.4 Active Implantable Medical Devices Market: Geographic Mix
4.5 Active Implantable Medical Devices Market: Developing vs Developed Countries/Regions
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Burden of Cardiovascular Diseases
5.2.1.2 Rising Prevalence of Neurological Disorders
5.2.1.3 Investments and Funds to Develop Technologically Advanced Products
5.2.1.4 Expanded Applications of Neurostimulators
5.2.1.5 Favorable Reimbursement Scenario for Ent Procedures in Developed Countries
5.2.2 Market Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the U.S.
5.2.2.2 Issues Related to the Use of Implantable Medical Devices
5.2.2.3 High Cost of Implants and an Unfavorable Reimbursement Scenario
5.2.3 Market Opportunities
5.2.3.1 Emerging Markets Offer Significant Growth Opportunities
5.2.3.2 Development of Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
5.2.4 Market Challenges
5.2.4.1 Increasing Pricing Pressure on Market Players
5.2.4.2 Dearth of Skilled Professionals
6 Industry Insights
6.1 Introduction
6.2 Key Industry Trends
6.2.1 Increasing Market Consolidation
6.2.2 Development of Innovative, Easy-To-Use Implantable Cardiovascular Products With Increased Longevity
6.2.3 Development of Technologically Advanced Implantable Hearing Devices and Expansion of Distribution Channel for Hearing Implants
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
6.3.4 Rest of the World
7 Global Active Implantable Medical Devices Market, By Product
7.1 Introduction
7.2 Implantable Cardioverter Defibrillators
7.2.1 Transvenous Implantable Cardioverter Defibrillators
7.2.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
7.2.1.2 Dual-Chamber Implantable Cardioverter Defibrillators
7.2.1.3 Single-Chamber Implantable Cardioverter Defibrillators
7.2.2 Subcutaneous Implantable Cardioverter Defibrillators
7.3 Implantable Cardiac Pacemakers
7.4 Ventricular Assist Devices
7.5 Implantable Heart Monitors/Insertable Loop Recorders
7.6 Neurostimulators
7.6.1 Spinal Cord Stimulators
7.6.2 Deep Brain Stimulators
7.6.3 Sacral Nerve Stimulators
7.6.4 Vagus Nerve Stimulators
7.6.5 Gastric Electrical Stimulators
7.7 Implantable Hearing Devices
7.7.1 Active Hearing Implants
7.7.2 Passive Hearing Implants
8 Global Active Implantable Medical Devices Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe (RoE)
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia-Pacific (Ro-APAC)
8.5 Latin America
8.6 Middle East and Africa
9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situations and Trends
9.3.1 Product Launches
9.3.2 Mergers & Acquisitions
9.3.3 Agreements, Partnerships, and Collaborations
9.3.4 Expansions
10 Company Profiles
10.1 Introduction
10.2 Abbott Laboratories
10.3 Medtronic PLC
10.4 Boston Scientific Corporation
10.5 Biotronik Se & Co., Kg
10.6 Livanova PLC
10.7 William Demant Holding A/S
10.8 Cochlear Limited
10.9 Sonova Holding AG
10.10 Med-EL
10.11 Nurotron Biotechnology Co. Ltd.
The Active Implantable Medical Devices Market has been segmented as below:
By Product Segment Analysis:
By Regional Analysis:
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE